BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21417348)

  • 1. 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).
    Sunderland PT; Woon EC; Dhami A; Bergin AB; Mahon MF; Wood PJ; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
    J Med Chem; 2011 Apr; 54(7):2049-59. PubMed ID: 21417348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor.
    Sunderland PT; Dhami A; Mahon MF; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
    Org Biomol Chem; 2011 Feb; 9(3):881-91. PubMed ID: 21127791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP).
    Watson CY; Whish WJ; Threadgill MD
    Bioorg Med Chem; 1998 Jun; 6(6):721-34. PubMed ID: 9681138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors.
    Pellicciari R; Camaioni E; Costantino G; Marinozzi M; Macchiarulo A; Moroni F; Natalini B
    Farmaco; 2003 Sep; 58(9):851-8. PubMed ID: 13679179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-pot tandem Hurtley-retro-Claisen-cyclisation reactions in the synthesis of 3-substituted analogues of 5-aminoisoquinolin-1-one (5-AIQ), a water-soluble inhibitor of PARPs.
    Woon EC; Sunderland PT; Paine HA; Lloyd MD; Thompson AS; Threadgill MD
    Bioorg Med Chem; 2013 Sep; 21(17):5218-27. PubMed ID: 23849206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Chen J; Peng H; He J; Huan X; Miao Z; Yang C
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2669-73. PubMed ID: 24815508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
    Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors.
    Suyavaran A; Ramamurthy C; Mareeswaran R; Shanthi YV; Selvakumar J; Mangalaraj S; Kumar MS; Ramanathan CR; Thirunavukkarasu C
    Bioorg Med Chem; 2015 Feb; 23(3):488-98. PubMed ID: 25555733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
    Jagtap PG; Baloglu E; Southan GJ; Mabley JG; Li H; Zhou J; van Duzer J; Salzman AL; Szabó C
    J Med Chem; 2005 Aug; 48(16):5100-3. PubMed ID: 16078828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
    Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors.
    Gangloff AR; Brown J; de Jong R; Dougan DR; Grimshaw CE; Hixon M; Jennings A; Kamran R; Kiryanov A; O'Connell S; Taylor E; Vu P
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4501-5. PubMed ID: 23850199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.
    Canan Koch SS; Thoresen LH; Tikhe JG; Maegley KA; Almassy RJ; Li J; Yu XH; Zook SE; Kumpf RA; Zhang C; Boritzki TJ; Mansour RN; Zhang KE; Ekker A; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR; Webber SE; Hostomsky Z
    J Med Chem; 2002 Nov; 45(23):4961-74. PubMed ID: 12408707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
    Wells GJ; Bihovsky R; Hudkins RL; Ator MA; Husten J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1151-5. PubMed ID: 16359865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
    Zhang J; Lautar S; Huang S; Ramsey C; Cheung A; Li JH
    Biochem Biophys Res Commun; 2000 Nov; 278(3):590-8. PubMed ID: 11095954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
    Chiarugi A; Meli E; Calvani M; Picca R; Baronti R; Camaioni E; Costantino G; Marinozzi M; Pellegrini-Giampietro DE; Pellicciari R; Moroni F
    J Pharmacol Exp Ther; 2003 Jun; 305(3):943-9. PubMed ID: 12606624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
    Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
    J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
    Pellicciari R; Camaioni E; Costantino G; Formentini L; Sabbatini P; Venturoni F; Eren G; Bellocchi D; Chiarugi A; Moroni F
    ChemMedChem; 2008 Jun; 3(6):914-23. PubMed ID: 18409175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Li JH; Zhang J; Smulson ME
    Nucleic Acids Res; 2001 Feb; 29(3):841-9. PubMed ID: 11160908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
    Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.